Zhi Li
About Zhi Li
Zhi Li is an Associate Director at Bristol Myers Squibb with extensive experience in biochemistry and biologics manufacturing.
Current Role at Bristol Myers Squibb
Zhi Li currently serves as Associate Director at Bristol Myers Squibb. In this role, he leads teams and oversees various aspects of process development and commercial manufacturing. His work focuses on delivering life-transforming medicines to patients, leveraging his expertise in protein chromatography and filtration. His leadership is characterized by a collaborative approach, which has established a strong rapport with colleagues and team members.
Previous Positions at Bristol Myers Squibb
Before his current role, Zhi Li held several positions at Bristol Myers Squibb. He was the Scientific Associate Director in Devens, MA for four months in 2022, and before that, he served as the Senior Principal Scientist for eight months from 2021 to 2022. From 2020 to 2021, he worked as Senior Manager. Li's initial role at the company was Scientist, Manufacturing Sciences & Technology - Downstream in East Syracuse, New York, which he held for three years from 2015 to 2018.
Experience at AbbVie
Zhi Li worked at AbbVie as a Senior Scientist II, Process Sciences - Purification from 2018 to 2020. Based in Worcester, Massachusetts, United States, Li contributed significantly to the field of purification within process sciences. His contributions included leading initiatives in large-scale manufacturing processes and regulatory support for biologics manufacturing.
Academic Background
Zhi Li holds a Doctor of Philosophy (Ph.D.) in Biochemistry from the University of Illinois at Urbana-Champaign, where he studied from 2006 to 2012. He also earned a Bachelor's degree in Biological Sciences from Tsinghua University, completing his studies there from 2002 to 2006. His academic background provides a strong foundation for his expertise in biochemistry and biological sciences.
Leadership and Team Management
Throughout his career, Zhi Li has demonstrated strong leadership skills, notably leading a team of 20 scientists and engineers in process development and commercial manufacturing support for monoclonal antibodies and fusion proteins. Known for his collaborative approach, he has successfully managed complex projects and contributed to delivering high-impact medicines.